1-7 of 7
Keywords: Baclofen
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Journal Articles
Eur Neurol (1987) 26 (3): 141–144.
Published Online: 06 February 2008
...Robert P. Iacono; Jennifer Linford; Ara Tourian; Reuven Sandyk Baclofen at 20–40 mg/day was used to successfully treat two post-amputation patients who developed continuous complex involuntary movements of the proximal extremity. These autonomous movements were otherwise recalcitrant to therapy...
Journal Articles
Eur Neurol (1985) 24 (6): 380–385.
Published Online: 01 February 2008
...C.F. Terrence; G.H. Fromm; R. Tenicela Baclofen has shown analgesic properties in a number of animal studies but has failed as a conventional analgesic in the human postoperative dental pain model. In order to test baclofen’s analgesic properties in more chronic pain conditions, we selected...
Journal Articles
Eur Neurol (1985) 24 (4): 286–288.
Published Online: 01 February 2008
...R. Sandyk A patient with neuroleptic-induced akathisia was successfully treated with a combination of baclofen (a GABA agonist) and clonazepam (a serotonergic agent). This suggests that agents bypassing the dopaminergic systems may be effective in the treatment of this distressing disorder. ©...
Journal Articles
Eur Neurol (1984) 23 (3): 163–165.
Published Online: 31 January 2008
...R. Sandyk A 58-year-old women with long-standing hemifacial spasm experienced dramatic relief of symptomatology while receiving baclofen (Lioresal®) in a daily dosage of 37.5 mg. Clinical response was noted within 48 h and she remained asymptomatic during 12 months of treatment. No toxic or side...
Journal Articles
Eur Neurol (1984) 23 (1): 51–55.
Published Online: 31 January 2008
...L. Steardo; A. Leo; E. Marano Baclofen (beta-4-chlorophenyl-gamma-aminobutyric acid) shows analgesic properties in rats and resembles carbamazepine and phenytoin in its effects on the spinal trigeminal nucleus of cats. We have, therefore, conducted a clinical trial in 25 subjects, 16 suffering from...
Journal Articles
Eur Neurol (1977) 16 (1-6): 257–262.
Published Online: 29 January 2008
...W. Cendrowski; W. Sobczyk 25 patients with multiple sclerosis (MS) and other spastic disorders, 33 MS patients and 10 control patients with MS were given clonazepam, baclofen or placebo over a period of 5 days to 20 weeks. Both clonazepam and baclofen were significantly more effective than placebo...